Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial

Fig. 2

Clinical response to neoadjuvant immunochemotherapy. A Response assessment with computerized tomography (CT) before the initiation of treatment and after two and three cycles of neoadjuvant immunochemotherapy. B Representative CT scans of patient who achieved partial response (PR) following the second cycle and further achieved complete response (CR) after the third cycle treatment. Red arrow indicates the local tumor lesion. CR: complete response; PR: partial response; SD: stable disease

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us